Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
21491868	s-kryog	— (—)	1279	1429	100.00%	Distribution not available
21491868	s-kryog	g/l (g/l)	172	244	43.85%
21491868	s-kryopre	— (—)	24	33	100.00%	Distribution not available
21491868	s-kryopre	g/l (g/l)	8	8	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other disorders of skin and subcutaneous tissue

431

682

5.85

228.75

1.3

1.2

1.02

0.29

g/l

1.43

Systemic connective tissue disorders

288

395

7.40

197.77

1.2

0.70

0.32

g/l

0.56

Ulcer of lower limb, not elsewhere classified

169

113

15.40

192.59

1.3

1.2

0.77

0.14

g/l

—

ILD medications: immunosuppressive drugs

359

623

5.57

184.66

1.3

1.1

0.65

0.55

g/l

0.11

ILD medications

550

707

4.29

169.68

1.3

1.1

0.36

0.54

g/l

0.35

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

489

839

4.20

163.55

1.3

1.1

0.60

0.47

g/l

0.20

ILD medications: prednisolone, methylprednisolone, prednisone

525

698

4.27

163.13

1.3

1.1

0.35

0.54

g/l

0.36

Oral corticosteroids

500

794

3.83

139.47

1.3

1.1

0.50

g/l

0.00

First line medication for Crohn's disease

500

716

3.83

133.80

1.2

0.36

0.52

g/l

0.32

Inflammatory bowel disease treatment related agents

520

814

3.65

132.61

1.3

1.1

0.50

0.49

g/l

0.02

Other and unspecified dermatitis

291

622

4.72

125.77

1.2

0.57

0.38

g/l

0.27

Other systemic involvement of connective tissue (FG)

190

271

7.06

124.93

1.2

0.30

0.24

g/l

0.17

Autoimmune diseases excluding thyroid diseases

472

705

3.73

123.19

1.2

0.58

0.42

g/l

0.25

Other systemic involvement of connective tissue

197

302

6.61

122.18

1.2

0.30

0.33

g/l

0.07

Autoimmune diseases excluding thyroid diseases, strict definition

458

684

3.75

120.39

1.2

0.50

0.43

g/l

0.10

Renal failure

238

408

5.38

115.99

1.4

1.2

0.16

0.55

g/l

0.95

Coagulation defects, purpura and other haemorrhagic conditions

165

231

7.27

111.48

1.5

1.2

0.94

0.25

g/l

0.72

Dermatitis

313

778

4.05

111.35

1.2

0.57

g/l

0.00

Diseases of the skin and subcutaneous tissue

407

527

3.89

107.50

1.2

0.33

0.46

g/l

0.23

Autoimmune diseases related-to ILD

387

990

3.46

105.73

1.2

0.43

0.57

g/l

0.20

Fever of other and unknown origin

263

557

4.41

102.19

1.3

1.2

0.79

0.44

g/l

0.41

Chronic kidney disease

169

276

6.16

97.88

1.3

1.2

0.09

0.45

g/l

1.30

Other bacterial diseases

397

825

3.34

95.97

1.2

0.25

0.69

g/l

1.18

Purpura and other haemorrhagic conditions

122

153

8.13

90.78

1.5

1.2

1.07

0.28

g/l

0.72

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

11.99

89.62

1.4

1.2

1.69

0.07

g/l

—

Diseases of arteries, arterioles and capillaries

300

600

3.75

87.99

1.2

0.53

0.67

g/l

0.14

L04AX Other immunosuppressants

276

744

3.74

87.69

1.3

1.2

0.59

0.38

g/l

0.34

Second line medication for Crohn's disease

280

765

3.68

87.22

1.3

1.2

0.59

0.38

g/l

0.36

Glomerular diseases

138

212

6.61

85.58

1.5

1.2

0.27

0.19

g/l

0.25

Primary_lymphoid and hematopoietic malignant neoplasms

147

252

5.90

81.61

1.5

1.1

1.25

0.12

g/l

1.87

Primary_lymphoid and hematopoietic malignant neoplasms

147

256

5.81

80.35

1.5

1.1

1.25

0.17

g/l

1.76

General symptoms and signs

424

702

3.04

79.12

1.2

0.26

0.42

g/l

0.39

Mixed connective tissue disease

11.41

79.03

1.2

1.3

0.16

0.28

g/l

—

Bacterial infection, other or unspecified

222

494

4.08

77.54

1.2

0.32

0.74

g/l

0.68

Autoimmune diseases

415

708

3.00

76.62

1.2

0.50

0.42

g/l

0.12

Dermatitis and eczema

422

994

2.79

74.72

1.2

0.51

0.55

g/l

0.05

Anaemias

124

106

7.84

74.03

1.2

1.1

0.12

0.17

g/l

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

13.48

73.68

1.5

1.3

1.69

0.07

g/l

—

Other and unspecified polyneuropathies, also in other diseases

126

209

6.11

72.49

1.5

1.2

0.58

0.17

g/l

1.02

Cardiovascular diseases

251

342

4.02

71.72

1.2

0.13

0.26

g/l

—

Tramadol

316

646

3.16

68.53

1.2

0.94

0.40

g/l

0.75

Used for control exclusion in common control thyroid runs

377

649

2.95

67.67

1.2

0.26

0.46

g/l

0.41

Polyneuropathies and other disorders of the peripheral nervous system

133

252

5.34

66.47

1.5

1.2

0.54

0.17

g/l

1.09

Finngen Rheumatological endpoints

371

748

2.84

64.77

1.2

0.22

0.44

g/l

0.64

Glomerulonephritis

111

7.99

63.87

1.7

1.2

0.38

0.10

g/l

—

Nephropathy related operations

131

7.22

62.62

1.5

1.2

0.50

0.37

g/l

—

Bacterial Sepsis

193

450

3.84

61.94

1.2

0.32

0.53

g/l

0.31

Renal tubulo-interstitial diseases

328

896

2.82

61.78

1.4

1.2

0.30

0.64

g/l

0.93

Aplastic and other anaemias

193

490

3.76

61.21

1.3

1.2

0.86

0.26

g/l

0.82

Other specified/unspecified systemic involvement of connective tissue

11.12

60.96

1.2

0.19

0.43

g/l

—

Dialysis, with operation codes

135

7.00

60.92

1.5

1.2

0.35

0.33

g/l

—

Septicaemia

165

382

4.18

60.83

1.3

1.2

0.07

0.57

g/l

1.47

Acute renal failure

111

196

5.72

59.88

1.5

1.2

0.23

0.50

g/l

—

Other septicaemia

150

335

4.42

59.87

1.3

1.2

0.07

0.61

g/l

—

Certain infectious and parasitic diseases

355

635

2.81

58.33

1.2

1.1

0.16

0.52

g/l

1.09

Cardiovascular diseases (excluding rheumatic etc)

259

459

3.27

57.34

1.2

0.11

0.40

g/l

1.39

Oedema, not elsewhere classified

135

292

4.63

57.31

1.4

1.2

1.75

0.18

g/l

—

Other and unspecified anaemias

174

443

3.82

56.93

1.3

1.2

0.93

0.26

g/l

0.68

Other anaemias

175

447

3.80

56.74

1.3

1.2

0.93

0.26

g/l

0.68

Implicit bacterial Sepsis

167

390

3.95

56.32

1.2

0.36

0.55

g/l

0.23

Reimbursement for rheumatic diseases

242

797

3.05

55.88

1.1

1.2

0.51

0.39

g/l

0.17

Explicit Sepsis

177

462

3.69

55.02

1.2

0.07

0.53

g/l

1.45

Erysipelas

204

553

3.38

54.81

1.2

0.06

0.62

g/l

—

Pain in limb

292

760

2.79

53.24

1.3

1.2

1.05

0.49

g/l

0.60

Cerebrovascular diseases (FINNGEN)

145

232

4.50

53.11

1.1

1.2

0.18

0.34

g/l

—

Polyarthropathies

268

630

2.85

49.56

1.2

0.42

0.54

g/l

0.21

Other soft tissue disorders, not elsewhere classified

329

792

2.57

49.34

1.2

0.87

0.48

g/l

—

Glomerular disorders in diseases classified elsewhere

121

6.62

49.26

1.2

0.09

0.13

g/l

—

Heart failure, not strict

258

645

2.77

45.87

1.3

1.2

0.16

0.79

g/l

1.76

Hypertensive diseases (excluding secondary)

205

366

3.27

45.57

1.3

1.2

0.15

0.43

g/l

1.01

Opioids

338

718

2.48

44.81

1.2

0.22

0.38

g/l

0.45

Urticaria and erythema

161

479

3.38

44.36

1.2

0.96

0.16

g/l

0.84

L04AA Selective immunosuppressants

118

284

4.19

44.25

1.2

0.19

0.25

g/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

110

162

4.78

42.84

1.2

0.59

0.40

g/l

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

7.09

41.12

1.4

1.2

1.80

0.34

g/l

—

Headache

212

637

2.79

40.39

1.2

1.17

0.41

g/l

0.84

Viral hepatitis

102

6.39

38.50

1.6

1.1

0.33

0.04

g/l

—

Persons encountering health services in other circumstances, wide

390

946

2.14

37.47

1.2

0.42

0.53

g/l

0.22

Heart failure and antihypertensive medication

106

158

4.46

37.39

1.2

0.13

0.42

g/l

—

Certain disorders involving the immune mechanism

236

4.19

36.80

1.8

1.1

0.91

0.14

g/l

1.09

Extracorporeal dialysis

7.58

36.55

1.5

1.2

0.09

0.12

g/l

—

Pain in joint

204

488

2.78

36.23

1.1

1.2

0.18

0.21

g/l

—

GASTRO-related operations

257

503

2.57

36.23

1.2

0.16

0.44

g/l

1.00

Any gastric operation

257

503

2.57

36.23

1.2

0.16

0.44

g/l

1.00

Hypertensive diseases

269

632

2.42

34.78

1.2

0.15

0.53

g/l

1.48

Hypertension

269

632

2.42

34.76

1.2

0.15

0.53

g/l

1.48

Codeine

297

708

2.31

34.60

1.2

0.67

0.38

g/l

0.25

Urticaria

127

386

3.31

33.96

1.2

1.16

0.17

g/l

—

Neurological diseases, wide definition

103

4.79

33.28

1.2

1.3

0.08

0.58

g/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

160

333

3.06

33.18

1.2

0.23

0.45

g/l

—

Other arthritis (FG)

117

343

3.43

33.13

1.3

1.2

0.60

0.19

g/l

—

Implicit Sepsis

230

740

2.42

32.60

1.3

1.2

0.35

0.76

g/l

0.79

Exposure to unspecified factor

306

1117

2.13

32.11

1.2

0.65

0.51

g/l

—

Other heart diseases

162

364

2.95

32.07

1.2

0.10

0.29

g/l

1.42

Enlarged lymph nodes

144

4.90

32.01

1.5

1.1

1.23

0.09

g/l

—

Hypertension, essential

255

619

2.36

31.43

1.2

0.14

0.53

g/l

1.49

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

301

910

2.16

31.37

1.2

0.24

0.61

g/l

1.18

Symptoms and signs involving the skin and subcutaneous tissue

227

970

2.34

31.28

1.3

1.2

0.94

0.54

g/l

—

Heart failure,strict

165

428

2.79

30.42

1.3

1.2

0.28

0.94

g/l

1.15

Abnormal findings on examination of blood, without diagnosis

157

533

2.77

30.38

1.5

1.1

1.59

0.30

g/l

1.34

Other disorders of veins

142

499

2.86

29.59

1.1

1.2

0.65

0.29

g/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

282

816

2.17

29.55

1.3

1.2

0.51

0.58

g/l

0.09

282

816

2.17

29.55

1.3

1.2

0.51

0.58

g/l

0.09

Malaise and fatigue

146

427

2.86

29.24

1.3

1.2

0.88

0.35

g/l

—

Other diseases of blood and blood-forming organs, wide

270

3.58

29.05

1.3

1.2

0.31

0.22

g/l

—

Diseases of the musculoskeletal system and connective tissue

171

305

2.82

28.70

1.2

1.3

0.11

0.59

g/l

—

Peripheral artery disease

136

375

2.93

28.21

1.3

1.2

0.93

0.69

g/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

252

837

2.19

28.08

1.3

1.2

0.31

0.72

g/l

0.92

Heart failure, strict

176

494

2.57

27.81

1.3

1.2

0.27

0.86

g/l

1.12

Examination and observation for other reasons

195

479

2.48

27.39

1.2

1.1

0.65

0.21

g/l

0.50

Infections of the skin and subcutaneous tissue

188

795

2.36

26.67

1.2

0.19

0.50

g/l

—

Pneumonias (Asthma/COPD co-morbidities)

299

1029

2.02

26.63

1.3

1.2

0.51

0.56

g/l

0.07

Soft tissue disorders

315

808

2.03

26.53

1.2

0.19

0.47

g/l

—

Antihypertensive medication - note that there are other indications

197

440

2.46

26.27

1.2

0.17

0.40

g/l

0.72

Persons encountering health services for other counselling and medical advice, not elsewhere classified

326

942

1.98

26.24

1.3

1.2

0.50

0.53

g/l

0.03

Pyoderma gangrenosum

17.13

25.70

1.5

1.0

—

g/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

126

349

2.90

25.61

1.2

0.84

0.52

g/l

—

Codeine or tramadol medication

345

996

1.92

25.47

1.2

0.52

0.48

g/l

0.04

Other specific joint derangements/joint disorders

229

699

2.20

25.37

1.1

1.2

0.18

0.52

g/l

—

All pneumoniae

298

1039

1.98

25.35

1.3

1.2

0.50

0.56

g/l

0.08

Venous thromboembolism

168

675

2.42

25.16

1.3

1.2

0.55

0.57

g/l

—

Unspecified kidney failure

5.51

25.05

1.6

1.2

0.11

0.37

g/l

—

Oxycodone

109

352

3.01

24.82

1.5

1.2

0.91

0.48

g/l

—

Other specified/unspecified arthritis

102

330

3.11

24.74

1.4

1.2

0.70

0.18

g/l

—

Influenza and pneumonia

309

1048

1.94

24.53

1.3

1.2

0.51

0.54

g/l

0.06

Dyspnoea

262

988

2.04

24.50

1.3

1.2

0.46

0.60

g/l

0.21

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

289

1033

1.97

24.24

1.3

1.2

0.53

0.56

g/l

0.05

All-cause Heart Failure

166

488

2.46

24.01

1.3

1.2

0.28

0.86

g/l

1.07

Complications of surgical and medical care, not elsewhere classified

287

1052

1.96

23.87

1.3

1.2

0.58

0.53

g/l

0.06

Asthma, excluding more controls

225

543

2.21

23.78

1.2

1.79

0.37

g/l

—

Pneumonia, organism unspecified

264

955

2.00

23.39

1.3

1.2

0.55

0.60

g/l

0.06

Arthropathies

280

709

2.01

23.08

1.2

0.21

0.51

g/l

0.88

Osteopathies and chondropathies

172

715

2.29

22.58

1.3

1.2

1.16

0.28

g/l

—

Symptoms and signs involving the circulatory and respiratory systems

304

791

1.93

22.22

1.2

0.25

0.52

g/l

0.80

Asthma

232

588

2.12

22.20

1.2

1.79

0.35

g/l

—

Abnormalities of breathing

263

785

1.99

22.04

1.2

0.49

0.52

g/l

0.03

STROKE

178

541

2.29

21.87

1.1

1.2

0.26

0.74

g/l

—

Parasetamol

236

577

2.09

21.54

1.2

0.27

0.61

g/l

0.78

Other heart diseases, wide

271

866

1.95

21.40

1.2

0.19

0.69

g/l

1.54

Diseases of the eye and adnexa

250

616

2.04

21.20

1.2

0.21

0.36

g/l

0.32

Endocrine, nutritional and metabolic diseases

244

610

2.04

20.86

1.2

0.26

0.53

g/l

0.65

Disturbances of skin sensation

101

361

2.81

20.61

1.5

1.2

1.21

0.20

g/l

—

Pain in throat and chest

245

754

1.99

20.59

1.2

0.90

0.53

g/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

185

805

2.14

20.47

1.4

1.2

0.62

0.55

g/l

0.07

Dental caries

316

2.93

20.40

1.3

1.2

0.19

0.26

g/l

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

139

4.06

20.37

1.6

1.2

1.46

0.09

g/l

—

Asthma (mode)

223

593

2.07

20.25

1.2

1.21

0.35

g/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

111

191

2.92

19.96

1.2

1.1

0.11

0.14

g/l

—

Cerebrovascular diseases

212

744

2.05

19.95

1.1

1.2

0.15

0.67

g/l

2.06

Pain (limb, back, neck, head abdominally)

211

500

2.12

19.82

1.2

0.22

0.21

g/l

0.06

Complications of procedures, not elsewhere classified

230

1019

1.95

19.79

1.3

1.2

0.38

0.54

g/l

0.30

Diseases of liver

112

433

2.60

19.63

1.1

1.2

0.33

0.19

g/l

—

Asthma (only as main-diagnosis), excluding more controls

194

543

2.13

19.45

1.2

1.07

0.37

g/l

—

Gout

253

3.04

19.32

1.2

0.39

0.52

g/l

—

Any reimbursement code in KELA

173

384

2.26

19.01

1.2

0.10

0.22

g/l

0.91

Metabolic disorders

263

872

1.88

18.80

1.2

0.44

0.41

g/l

0.05

Rheumatoid arthritis

107

372

2.62

18.79

1.1

1.2

0.25

0.40

g/l

—

Rash and other nonspecific skin eruption

109

4.35

18.71

1.2

1.3

—

0.25

g/l

—

Dentinal caries

280

2.93

18.06

1.3

1.2

0.19

0.27

g/l

—

Asthma (only as main-diagnosis)

198

588

2.04

17.73

1.2

1.07

0.35

g/l

—

Heart failure and bmi 25plus

100

255

2.71

17.52

1.4

1.2

0.16

0.97

g/l

—

Non-ischemic cardiomyopathy

280

2.74

17.34

1.4

1.1

0.37

0.34

g/l

0.05

Haemorrhage from respiratory passages

355

2.60

17.15

1.2

0.47

0.50

g/l

—

Asthma, unspecified (mode), excluding more controls

139

485

2.26

17.13

1.3

1.2

1.21

0.41

g/l

—

Excluding asthma or asthma-COPD overlap

229

596

1.93

16.85

1.2

0.23

0.35

g/l

0.35

Disorders of other endocrine glands

131

577

2.24

16.63

1.2

0.31

0.26

g/l

—

Stroke, excluding SAH

166

596

2.07

16.44

1.1

1.2

0.17

0.69

g/l

—

Gout, FINNGEN

308

2.74

16.43

1.2

0.39

0.50

g/l

—

Other pulmonary diagnosis

227

596

1.91

16.31

1.2

0.22

0.35

g/l

0.40

Hard cardiovascular diseases

215

728

1.90

16.13

1.2

0.17

0.70

g/l

1.82

Covid-19 confirmed case

352

2.60

16.02

1.1

1.2

0.72

0.30

g/l

—

COPD differential diagnosis

225

593

1.90

15.99

1.2

0.23

0.35

g/l

0.35

ILD differential diagnosis

225

593

1.90

15.99

1.2

0.23

0.35

g/l

0.35

DVT of lower extremities and pulmonary embolism

120

526

2.28

15.96

1.2

0.63

0.22

g/l

—

Other disorders of fluid, electrolyte and acid-base balance

329

2.62

15.84

1.3

1.2

0.19

0.18

g/l

—

Cardiac arrhythmias

171

555

2.04

15.82

1.2

0.19

0.81

g/l

1.56

Genitourinary diseases

175

424

2.07

15.72

1.2

0.15

0.75

g/l

1.20

Asthma, unspecified (mode)

142

525

2.15

15.64

1.3

1.2

1.21

0.39

g/l

—

Bleeding

218

857

1.85

15.63

1.2

1.11

0.42

g/l

0.64

Dorsalgia

274

844

1.76

15.59

1.2

0.37

0.61

g/l

—

Persons encountering health services for specific procedures and health care

290

1048

1.72

15.57

1.3

1.2

0.34

0.61

g/l

0.54

Diarrhoea and gastroenteritis of presumed infectious origin

196

944

1.89

15.55

1.2

0.77

0.42

g/l

—

Fall on same level

313

1038

1.69

15.44

1.2

0.62

0.54

g/l

0.07

Low back pain

201

822

1.89

15.39

1.3

1.2

0.39

0.62

g/l

—

Medical observation and evaluation for suspected diseases and conditions

187

482

1.99

15.20

1.2

1.1

0.81

0.21

g/l

—

Complications of medical and surgical care

198

1010

1.87

15.19

1.3

1.2

0.24

0.65

g/l

1.30

Rheumatoid arthritis, including avohilmo

118

527

2.25

15.17

1.1

1.2

0.24

0.29

g/l

—

Other diseases of urinary system

276

896

1.74

15.10

1.1

1.2

0.30

0.60

g/l

0.75

Provisional assignment of new diseases of uncertain etiology

134

631

2.13

15.09

1.2

0.74

0.26

g/l

—

Codes for special purposes

134

631

2.13

15.09

1.2

0.74

0.26

g/l

—

Asthma, hospital admission 2, infections

162

806

1.98

14.99

1.2

0.20

0.24

g/l

—

Asthma-related infections

162

806

1.98

14.99

1.2

0.20

0.24

g/l

—

Hypothyroidism, strict autoimmune

168

557

2.00

14.78

1.2

0.32

0.51

g/l

—

Ischaemic Stroke, excluding all haemorrhages

153

566

2.05

14.77

1.1

1.2

0.19

0.68

g/l

—

Stroke, including SAH

170

639

1.97

14.75

1.1

1.2

0.17

0.63

g/l

—

Atrial fibrillation and flutter

213

2.67

14.70

1.3

1.2

0.07

0.34

g/l

1.52

Neurological diseases

234

648

1.82

14.62

1.2

0.31

0.58

g/l

0.58

Episodal and paroxysmal disorders

307

939

1.68

14.58

1.2

0.32

0.52

g/l

0.60

Abnormal findings on diagnostic imaging of lung

128

584

2.14

14.56

1.4

1.2

0.36

0.46

g/l

—

Other joint disorders

239

709

1.80

14.55

1.2

0.12

0.51

g/l

—

COPD/asthma/ILD related infections

281

819

1.72

14.53

1.2

0.30

0.58

g/l

0.65

COPD/asthma related infections

281

819

1.72

14.53

1.2

0.30

0.58

g/l

0.65

Other and unspecified iron deficiency

396

2.41

14.33

1.2

0.89

0.23

g/l

—

Methotrexate

133

3.55

14.29

1.0

1.1

1.09

0.27

g/l

—

Other disorders of urethra and urinary system

188

751

1.88

14.20

1.2

0.56

0.57

g/l

—

Intestinal infectious diseases

249

1128

1.72

14.17

1.2

0.62

0.53

g/l

—

Intracranial trauma

146

533

2.05

14.14

1.3

1.2

0.14

0.67

g/l

—

Nerve, nerve root and plexus disorders

281

1052

1.68

14.08

1.3

1.2

0.56

0.54

g/l

0.03

Spondylopathies

212

706

1.83

14.03

1.2

0.71

0.58

g/l

—

Concussion

128

523

2.12

13.98

1.3

1.2

0.15

0.67

g/l

—

Gastrointestinal diseases

175

445

1.97

13.87

1.2

0.26

0.55

g/l

0.53

Disorders of sclera, cornea, iris and ciliary body

153

782

1.96

13.83

1.3

1.2

0.50

0.22

g/l

—

Atopic dermatitis

146

623

2.00

13.65

1.2

0.48

0.31

g/l

—

Thrombocytopenia, unspecified

4.35

13.58

1.2

0.13

0.11

g/l

—

Seropositive rheumatoid arthritis

284

2.61

13.25

1.1

1.2

0.24

0.25

g/l

—

Dorsopathies

278

847

1.68

13.24

1.2

0.22

0.61

g/l

1.27

Visual disturbances and blindness

138

692

2.00

13.20

1.4

1.2

0.29

0.25

g/l

—

Other dorsopathies, not elsewhere classified

269

845

1.68

13.05

1.2

0.26

0.61

g/l

0.93

Varicose veins

160

630

1.92

13.02

1.1

1.2

0.74

0.55

g/l

—

Psoriasis

377

2.37

13.02

1.1

1.2

0.05

0.22

g/l

—

Non-follicular lymphoma, hilmo, excluding all cancers

104

3.78

12.97

1.9

1.2

1.59

0.06

g/l

—

Symptoms and signs involving the digestive system and abdomen

268

798

1.69

12.94

1.2

0.12

0.51

g/l

1.55

Viral infections characterized by skin and mucous membrane lesions

118

565

2.09

12.79

1.4

1.2

0.38

0.21

g/l

0.34

Lymphoid leukaemia

4.96

12.63

1.8

1.3

0.31

0.06

g/l

—

Spondylosis

139

604

1.98

12.59

1.3

1.2

1.21

0.63

g/l

—

Abdominal and pelvic pain

265

798

1.67

12.46

1.2

0.56

0.51

g/l

0.06

Acute tubulo-interstitial nephritis

149

691

1.92

12.39

1.3

1.2

0.44

0.65

g/l

—

Lymphoid leukaemia

4.87

12.38

1.8

1.2

0.31

0.06

g/l

—

Asthma (diagnoses ohter than nonallergic)

225

1138

1.69

12.36

1.2

1.21

0.48

g/l

—

Cystitis

223

795

1.72

12.11

1.1

1.2

0.59

0.54

g/l

—

Diseases of oesophagus, stomach and duodenum

272

1019

1.62

11.96

1.2

1.10

0.38

g/l

0.72

Neoplasms

209

638

1.76

11.95

1.2

0.27

0.17

g/l

0.41

Asthma, including avohilmo

303

1113

1.58

11.93

1.2

1.46

0.42

g/l

—

Non-follicular lymphoma

111

3.54

11.83

1.9

1.2

1.59

0.10

g/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

151

811

1.87

11.82

1.2

0.32

0.55

g/l

—

Disorders of lens

170

584

1.84

11.70

1.3

1.2

0.35

0.62

g/l

0.47

Visual disturbances

126

640

1.97

11.69

1.4

1.2

0.29

0.25

g/l

—

Bacterial pneumonia, not elsewhere classified

102

421

2.15

11.64

1.3

1.1

0.12

0.57

g/l

—

Gout, strict definition

195

2.84

11.60

1.3

1.2

0.11

0.28

g/l

—

Disorders of eyelid, lacrimal system and orbit

213

988

1.69

11.58

1.2

0.53

0.58

g/l

0.06

Chronic periodontitis

179

2.92

11.57

1.7

1.2

0.18

0.32

g/l

—

Other respiratory diseases principally affecting the interstitium

190

2.86

11.54

1.3

1.2

0.27

0.24

g/l

—

Injuries to the head

279

1143

1.59

11.51

1.2

0.16

0.61

g/l

2.23

Bacterial pneumoniae

105

441

2.11

11.48

1.3

1.1

0.12

0.54

g/l

—

Lower back pain or/and sciatica

263

1136

1.61

11.45

1.3

1.2

0.38

0.56

g/l

—

Mycoses

343

2.34

11.45

1.4

1.2

1.57

0.23

g/l

—

Iron deficiency anaemia

109

528

2.05

11.23

1.2

0.89

0.22

g/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

174

482

1.83

11.20

1.2

1.1

0.21

g/l

0.01

Factors influencing health status and contact with health services

182

2.40

11.14

1.2

1.1

0.07

0.23

g/l

—

Other and unspecified effects of external causes

360

2.29

11.12

1.2

0.16

0.22

g/l

—

Nutritional anaemias

123

613

1.96

11.10

1.2

1.09

0.22

g/l

—

Gout, idiopatic and unspecified

276

2.47

11.00

1.2

0.10

0.25

g/l

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

240

1003

1.63

10.97

1.2

0.40

0.62

g/l

0.41

Persons encountering health services for examination and investigation

174

482

1.81

10.86

1.2

1.1

0.23

0.21

g/l

0.05

Polyarteritis nodosa

29.51

10.84

1.4

1.0

—

Fibromyalgia

3.90

10.82

1.1

1.2

—

0.32

g/l

—

288

970

1.57

10.76

1.2

0.31

0.55

g/l

0.62

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

157

877

1.79

10.75

1.3

1.2

0.28

0.57

g/l

—

Mood disorders, excluding more controls

250

946

1.61

10.70

1.3

1.2

0.90

0.51

g/l

—

Diabetic nephropathy, excluding more controls

109

3.23

10.62

1.2

0.10

1.15

g/l

—

Bacterial pneumonia (organism specified)

112

513

1.99

10.56

1.3

1.2

0.12

0.34

g/l

—

Subjective visual disturbances

312

2.35

10.56

1.6

1.2

0.34

0.30

g/l

—

Other antidepressants

264

864

1.60

10.56

1.2

0.84

0.40

g/l

0.38

Diseases of pulp and periapical tissues

455

2.09

10.41

1.5

1.2

0.63

0.62

g/l

0.01

Syncope and collapse

402

2.10

10.26

1.1

1.2

0.64

0.58

g/l

—

Zoster [herpes zoster]

193

2.71

10.11

1.5

1.2

0.58

0.25

g/l

—

Chronic lower respiratory diseases

304

1080

1.52

10.07

1.2

1.43

0.42

g/l

—

Senile cataract

151

517

1.81

10.00

1.4

1.2

0.74

0.67

g/l

0.06

Other acute lower respiratory infections

134

699

1.83

9.95

1.2

0.23

0.26

g/l

—

Falls/tendency to fall

282

913

1.55

9.86

1.2

0.14

0.47

g/l

1.63

Nausea and vomiting

298

2.32

9.83

1.3

1.2

0.66

0.27

g/l

—

Diseases of the respiratory system

173

494

1.76

9.82

1.2

0.24

0.41

g/l

0.38

Depression or dysthymia

183

601

1.71

9.65

1.2

0.56

0.46

g/l

0.08

Other external causes of accidental injury

210

638

1.65

9.56

1.2

0.26

0.41

g/l

0.40

Accidents

210

638

1.65

9.56

1.2

0.27

0.41

g/l

0.38

Type 2 diabetes, wide definition

195

775

1.64

9.24

1.2

0.51

0.64

g/l

0.10

Papulosquamous disorders

105

546

1.93

9.22

1.1

1.2

0.05

0.30

g/l

—

Sequelae of cerebrovascular disease

369

2.07

9.16

1.1

1.2

0.24

0.51

g/l

—

Constipation

209

937

1.60

9.08

1.3

1.2

0.56

0.53

g/l

0.03

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

144

830

1.74

9.05

1.3

1.2

0.28

0.47

g/l

—

Mood [affective] disorders

256

1103

1.53

9.00

1.2

0.90

0.51

g/l

—

Other diseases of pleura

106

491

1.92

8.98

1.3

1.2

0.19

0.44

g/l

—

Mood disorders

256

1105

1.52

8.87

1.2

0.90

0.51

g/l

—

Myalgia

255

2.36

8.86

1.0

1.2

—

0.21

g/l

—

Symptoms and signs involving speech and voice

444

2.01

8.82

1.2

0.73

0.15

g/l

—

Anxiety disorders, excluding more controls

212

887

1.59

8.80

1.3

1.2

0.56

0.53

g/l

—

Disorders of lipoprotein metabolism and other lipidaemias

191

738

1.63

8.74

1.2

0.20

0.44

g/l

0.70

Other disorders of kidney and ureter

151

2.80

8.73

1.4

1.2

0.04

0.31

g/l

—

Anxiety (asthma-related co-morbidities)

158

738

1.69

8.69

1.3

1.2

0.70

0.27

g/l

—

Use of hypnotics and sedatives

265

1016

1.51

8.61

1.3

1.2

0.71

0.44

g/l

0.33

Voice disturbances

342

2.14

8.56

1.2

0.78

0.13

g/l

—

Bronchitis

259

1129

1.51

8.53

1.2

0.45

0.55

g/l

0.13

External causes of morbidity and mortality

170

507

1.68

8.37

1.2

0.27

0.47

g/l

0.47

Depression

236

1069

1.52

8.25

1.3

1.2

0.92

0.51

g/l

—

Non-rheumatic valve diseases

105

407

1.89

8.22

1.2

0.62

1.14

g/l

—

Care involving use of rehabilitation procedures

153

874

1.66

8.21

1.3

1.2

0.17

0.66

g/l

—

Asthma, hospital admissions , main diagnosis only

201

1155

1.56

8.21

1.2

1.07

0.49

g/l

—

Valvular heart disease excluding rheumatic fever

105

408

1.88

8.19

1.2

0.62

1.14

g/l

—

Other diseases of intestines

257

998

1.50

8.10

1.2

0.33

0.47

g/l

—

Triptan medication for migraine, min. 3 purchases

144

672

1.69

8.02

1.2

0.99

0.21

g/l

—

Gout, unspecified

230

2.36

7.98

1.3

1.2

0.11

0.28

g/l

—

Seropositive rheumatoid arthritis, wide

359

2.07

7.96

1.1

1.2

0.24

0.29

g/l

—

Benign neoplasms

195

697

1.58

7.86

1.1

1.2

0.18

0.17

g/l

0.07

All anxiety disorders

159

782

1.64

7.86

1.3

1.2

0.70

0.28

g/l

—

Disorders of choroid and retina

184

847

1.58

7.78

1.2

0.67

0.53

g/l

—

Selective serotonin reuptake inhibitors

246

864

1.50

7.68

1.2

0.50

0.40

g/l

0.16

Disorders of gallbladder, biliary tract and pancreas

232

995

1.50

7.63

1.3

1.2

0.30

0.62

g/l

0.84

Benign neoplasms

244

913

1.49

7.55

1.2

0.29

0.45

g/l

0.43

Adverse effects, not elsewhere classified

264

2.20

7.37

1.3

1.2

0.14

0.24

g/l

—

Acute upper respiratory infections

248

1058

1.47

7.28

1.2

0.32

0.55

g/l

0.58

Symptoms and signs involving the urinary system

177

874

1.57

7.27

1.4

1.2

0.87

0.47

g/l

0.47

Neurotic, stress-related and somatoform disorders

218

1035

1.50

7.21

1.3

1.2

0.55

0.48

g/l

—

Parodontitis

212

1041

1.50

7.15

1.3

1.2

0.60

0.51

g/l

0.11

Parodontitis or operation codes

212

1041

1.50

7.12

1.3

1.2

0.60

0.51

g/l

0.11

Chronic periodontitis, including avohilmo

211

1041

1.50

7.09

1.3

1.2

0.60

0.51

g/l

0.11

Statin medication

184

660

1.57

7.09

1.2

0.16

0.49

g/l

1.37

Other/unspecified seropositive rheumatoid arthritis

356

2.00

7.04

1.1

1.2

0.24

0.30

g/l

—

Atrial fibrillation and flutter with reimbursement

162

2.26

7.02

1.2

0.09

0.37

g/l

—

Gingivitis and periodontal diseases

213

726

1.52

7.00

1.2

0.29

0.55

g/l

0.53

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

350

2.01

6.99

1.1

1.2

0.24

0.30

g/l

—

Intracranial injury

130

759

1.66

6.96

1.2

0.14

0.48

g/l

—

Disorders of skin appendages

119

705

1.69

6.90

1.1

1.2

0.42

0.24

g/l

—

Benzodiazepine use

235

1145

1.46

6.90

1.3

1.2

1.19

0.48

g/l

—

Anxiety disorders

218

1044

1.48

6.84

1.3

1.2

0.56

0.49

g/l

—

Keratitis

481

1.83

6.76

1.1

1.2

0.27

0.26

g/l

—

Persons with potential health hazards related to communicable diseases

556

1.77

6.75

1.1

1.2

1.14

0.24

g/l

—

Chronic periapical parodontitis

261

2.15

6.75

1.6

1.2

0.82

0.27

g/l

—

Other anxiety disorders

118

621

1.69

6.70

1.4

1.1

0.79

0.28

g/l

—

All influenza

298

2.05

6.52

1.2

1.1

0.23

0.31

g/l

—

Acute upper respiratory infections of multiple and unspecified sites

176

864

1.53

6.48

1.2

0.47

0.35

g/l

0.14

Diabetic nephropathy

174

2.39

6.47

1.2

0.10

0.60

g/l

—

General examination and investigation of persons without complaint and reported diagnosis

146

481

1.62

6.41

1.3

1.1

0.25

0.21

g/l

—

Haemophagocytic lymphohistiocytosis

+∞

6.38

1.3

0.0

—

g/l

—

Pure hypercholesterolaemia

156

668

1.57

6.34

1.3

1.2

0.56

0.44

g/l

0.11

Other nutritional deficiencies

151

949

1.56

6.32

1.2

0.14

0.59

g/l

—

Other retinal disorders

138

694

1.60

6.29

1.3

1.2

0.91

0.61

g/l

—

Parodontitis and operation codes

196

1033

1.48

6.19

1.2

0.61

0.51

g/l

0.11

Injury, poisoning and certain other consequences of external causes

140

433

1.62

6.16

1.2

0.27

0.47

g/l

0.41

Substance abuse, excluding more controls

127

689

1.62

6.12

1.4

1.2

0.15

0.35

g/l

—

Psychiatric diseases

266

945

1.41

6.10

1.2

0.88

0.51

g/l

0.31

Disorders of the thyroid gland

221

1000

1.45

6.10

1.2

0.47

0.54

g/l

0.09

Irregular menses

116

569

1.66

6.10

1.2

1.49

0.46

g/l

—

Other functional intestinal disorders

551

1.71

6.06

1.3

1.2

0.17

0.38

g/l

—

Other neurological diseases

159

835

1.53

6.05

1.1

1.2

0.24

0.62

g/l

—

Injuries to the knee and lower leg

274

1130

1.39

5.92

1.2

0.83

0.50

g/l

—

458

1.77

5.88

1.3

1.2

1.26

0.40

g/l

—

Dental pulpitis 1

255

942

1.41

5.84

1.3

1.2

0.33

0.29

g/l

0.07

Biological medicines for asthma

5.61

5.83

1.1

—

g/l

—

Diseases of pulp and periapical tissues, including avohilmo

254

939

1.41

5.79

1.3

1.2

0.33

0.29

g/l

0.07

Dental pulpitis 4

254

942

1.40

5.70

1.3

1.2

0.33

0.29

g/l

0.07

Diseases of oral cavity, salivary glands and jaws

206

727

1.45

5.64

1.2

0.30

0.55

g/l

0.49

Rosacea

151

2.39

5.62

1.2

—

0.15

g/l

—

Olecranon bursitis

3.30

5.58

1.2

—

0.17

g/l

—

Asthma and allergy, excluding more controls

138

2.44

5.53

1.1

1.2

—

0.19

g/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

217

1073

1.42

5.52

1.2

0.50

0.55

g/l

0.07

Any mental disorder

266

965

1.38

5.46

1.2

0.82

0.50

g/l

0.29

Other/unspecified enthesopathies, not elsewhere classified

2.90

5.45

1.2

—

0.25

g/l

—

Asthma and allergy

139

2.42

5.45

1.1

1.2

—

0.18

g/l

—

Unspecified haematuria

452

1.71

5.41

1.5

1.2

0.40

0.38

g/l

—

Actinic keratosis

406

1.78

5.36

1.3

1.2

1.26

0.22

g/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

213

993

1.42

5.35

1.2

0.48

0.52

g/l

0.05

Hypothyroidism, other/unspecified

205

951

1.42

5.30

1.2

0.52

0.55

g/l

—

Ischemic heart diseases

171

727

1.47

5.25

1.3

1.2

0.17

0.69

g/l

1.82

Sciatica+with lumbago

114

684

1.58

5.21

1.3

1.2

0.32

0.64

g/l

—

Skin changes due to chronic exposure to nonionizing radiation

423

1.75

5.17

1.3

1.2

1.26

0.22

g/l

—

Ischaemic heart disease, wide definition

168

715

1.47

5.13

1.2

0.10

0.61

g/l

2.25

Triptan medication for migraine, single purchase ok

183

860

1.44

5.10

1.3

1.2

0.30

0.28

g/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

183

860

1.44

5.10

1.3

1.2

0.30

0.28

g/l

—

Insulin, intermediate and long-acting

119

750

1.56

5.09

1.1

1.2

0.09

0.53

g/l

1.77

Obesity and other hyperalimentation

140

924

1.50

5.07

1.2

0.14

0.60

g/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

133

808

1.52

5.04

1.2

0.09

0.52

g/l

1.83

Open wound of ankle and foot

128

2.43

5.03

1.4

1.1

0.58

0.10

g/l

—

Coxarthrosis [arthrosis of hip](FG)

101

449

1.63

4.97

1.2

0.98

0.41

g/l

—

Symptoms and signs concerning food and fluid intake

2.81

4.96

1.2

—

0.07

g/l

—

Other intervertebral disc disorders

183

782

1.43

4.88

1.2

0.40

0.63

g/l

—

Malignant neoplasm

199

836

1.41

4.88

1.3

1.1

0.54

0.29

g/l

0.44

Dental pulpitis 2

164

570

1.47

4.88

1.2

1.1

0.31

0.21

g/l

0.21

Chronic periodontitis, complicated

118

2.47

4.87

2.0

1.2

0.26

0.10

g/l

—

Insulin medication

133

754

1.51

4.86

1.2

0.09

0.44

g/l

1.86

Melanocytic naevi

354

1.81

4.86

1.1

0.12

0.11

g/l

—

Diseases of the digestive system

601

1.61

4.83

1.2

1.55

0.33

g/l

—

Insulin, fast-acting

488

1.68

4.82

1.2

0.09

0.30

g/l

—

Substance abuse

127

804

1.51

4.75

1.4

1.2

0.15

0.43

g/l

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

201

848

1.40

4.73

1.2

1.1

0.49

0.29

g/l

0.38

Malignant neoplasm, wide definition for exclusion

201

848

1.40

4.73

1.2

1.1

0.49

0.29

g/l

0.38

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

201

848

1.40

4.73

1.2

1.1

0.49

0.29

g/l

0.38

Visual field defects

2.62

4.72

1.1

1.3

—

0.24

g/l

—

Obesity

138

924

1.48

4.71

1.2

0.14

0.60

g/l

—

Mental and behavioural disorders due to psychoactive substance use

130

819

1.50

4.68

1.4

1.2

0.15

0.43

g/l

—

Disorders of conjunctiva

183

1089

1.41

4.67

1.1

1.2

0.67

0.46

g/l

—

Other cataract

431

1.64

4.65

1.3

1.2

0.10

0.55

g/l

—

Diverticular disease of intestine

148

668

1.47

4.63

1.2

1.84

0.49

g/l

—

Conjunctivitis

169

1038

1.42

4.56

1.1

1.2

0.74

0.39

g/l

—

Gastro-oesophageal reflux disease

143

871

1.46

4.43

1.2

1.05

0.34

g/l

—

Type 1 diabetes

351

1.77

4.37

1.2

0.08

0.24

g/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

100

2.51

4.37

1.4

1.3

1.18

0.24

g/l

—

Insulin, fast-acting or short human

502

1.64

4.36

1.2

0.09

0.29

g/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

426

1.69

4.36

1.2

—

0.25

g/l

—

GI-bleeding

389

1.73

4.35

1.3

1.2

1.78

0.32

g/l

—

Sleep disorders (combined)

220

1065

1.35

4.32

1.2

0.77

0.51

g/l

0.23

Ganglion

245

1.92

4.32

1.1

1.2

—

0.21

g/l

—

Dental operations

152

536

1.46

4.31

1.2

0.13

0.26

g/l

1.06

Cardiodefibrillation

443

1.67

4.28

1.2

0.12

0.55

g/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

396

1.59

4.27

1.2

1.1

0.24

0.22

g/l

—

Dental pulpitis 4, only avohilmo

251

985

1.33

4.23

1.3

1.2

0.69

0.37

g/l

0.43

Bullous disorders

2.85

4.22

1.2

1.3

—

0.06

g/l

—

Migraine without aura and triptan purchases

206

2.00

4.20

1.1

1.2

—

0.20

g/l

—

Excessive attrition of teeth

272

1.66

4.19

1.2

0.33

1.06

g/l

—

Calcific aortic valvular stenosis

320

1.78

4.17

1.3

1.2

1.03

0.36

g/l

—

Calcific aortic valvular stenosis, operated

320

1.78

4.17

1.3

1.2

1.03

0.36

g/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

320

1.78

4.17

1.3

1.2

1.03

0.36

g/l

—

Operations 2 for CAVS

320

1.78

4.17

1.3

1.2

1.03

0.36

g/l

—

Other diseases of hard tissues of teeth

136

699

1.45

4.09

1.2

0.24

0.55

g/l

—

Dental pulpitis 1, only avohilmo

250

987

1.32

4.06

1.3

1.2

0.69

0.37

g/l

0.43

Systemic disorders of connective tissue in diseases classified elsewhere

10.43

4.05

1.3

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

323

1.76

4.05

1.3

1.2

1.03

0.35

g/l

—

Dysphagia

280

1.83

4.03

1.1

1.2

0.18

0.30

g/l

—

Other and unspecified rosacea

111

2.35

3.99

1.1

1.2

—

0.16

g/l

—

Crohn's disease NAS

2.54

3.96

1.2

1.1

—

0.04

—

Diabetes mellitus

227

1019

1.33

3.94

1.2

0.11

0.59

g/l

2.65

5-aminosalicylic acid

212

1.94

3.89

1.2

1.1

—

0.26

g/l

—

Dental caries, including avohilmo

177

653

1.39

3.88

1.2

0.34

0.43

g/l

0.15

Dental caries 1

177

653

1.39

3.88

1.2

0.34

0.43

g/l

0.15

COPD

451

1.57

3.86

1.3

1.2

1.20

0.32

g/l

—

Shoulder lesions

155

675

1.41

3.83

1.2

0.99

0.49

g/l

—

Dental caries 3

187

698

1.37

3.83

1.2

0.33

0.44

g/l

0.19

Excessive vomiting in pregnancy

107

2.35

3.82

1.1

—

0.19

g/l

—

Open wound of head

104

688

1.49

3.75

1.1

1.2

0.18

0.47

g/l

—

Visual impairment including blindness (binocular or monocular)

2.74

3.75

1.2

—

0.36

g/l

—

Nonorganic sleeping disorders, excluding more controls

223

1.89

3.71

1.2

1.1

—

0.25

g/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

182

918

1.35

3.65

1.2

0.29

0.46

g/l

—

Cholelithiasis, broad definition with cholecystitis

180

911

1.35

3.64

1.3

1.2

0.36

0.66

g/l

0.70

Dental pulpitis 2, only avohilmo

161

594

1.39

3.59

1.2

0.36

0.35

g/l

0.01

Other diseases of upper respiratory tract

245

985

1.30

3.52

1.2

0.70

0.48

g/l

0.22

Respiratory disorders in diseases classified elsewhere

5.37

3.52

1.3

1.1

—

g/l

—

Cholelithiasis

174

903

1.35

3.51

1.2

0.30

0.66

g/l

—

Rotator cuff syndrome

119

615

1.44

3.47

1.3

1.2

1.08

0.44

g/l

—

Arthrosis

149

590

1.39

3.41

1.2

0.20

0.54

g/l

—

Diaphragmatic hernia

473

1.57

3.40

1.4

1.2

1.55

0.41

g/l

—

Trigeminal neuralgia

2.67

3.39

1.1

1.3

—

0.36

g/l

—

Dental caries 1 and operation codes

192

738

1.34

3.39

1.2

0.34

0.42

g/l

0.14

Diabetes, varying definitions

222

1020

1.30

3.36

1.2

0.11

0.59

g/l

2.65

Propionic acid derivatives

208

1.65

3.36

1.2

1.3

0.05

0.29

g/l

—

Weight loss

114

2.20

3.34

1.2

1.3

—

0.23

g/l

—

Polycystic ovarian syndrome, consortium definition

154

678

1.37

3.33

1.2

0.79

0.42

g/l

—

Obesity due to excess calories

670

1.46

3.30

1.2

0.14

0.24

g/l

—

Orchitis and epididymitis

102

2.26

3.28

1.2

—

0.13

g/l

—

Disorders of continuity of bone

109

2.21

3.25

1.3

1.2

—

0.34

g/l

—

Melanocytic naevi

401

1.60

3.22

1.1

1.2

0.12

0.22

g/l

—

Erosion of teeth

5.39

3.20

1.4

1.1

—

Fall on same level involving ice and snow

119

849

1.40

3.19

1.3

1.2

0.56

0.50

g/l

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

3.35

3.19

1.3

—

0.06

—

Presence of other functional implants

110

543

1.44

3.19

1.2

0.35

0.67

g/l

—

Open wound of forearm

110

2.19

3.18

1.0

1.2

—

0.26

—

Dental caries 3, only avohilmo

187

722

1.33

3.16

1.2

0.35

0.43

g/l

0.13

Glucagon-like peptide-1 (GLP-1) analogues

109

628

1.43

3.16

1.1

1.3

0.09

0.63

g/l

—

Dental caries 1, only avohilmo

178

683

1.33

3.14

1.2

0.36

0.42

g/l

0.10

Faecal incontinence

2.25

3.12

1.3

1.2

—

0.37

—

Other diseases of the digestive system

390

1.59

3.08

1.3

1.2

1.78

0.32

g/l

—

Aortic aneurysm

212

1.81

3.08

1.2

0.13

0.29

g/l

—

Crohn disease (strict definition, require KELA)

2.34

3.07

1.3

1.1

—

0.04

g/l

—

Parodontitis or/and operation codes

140

609

1.37

3.01

1.3

1.2

0.37

0.79

g/l

0.65

Other or unspecified immunodeficiency

10.33

3.00

1.0

—

g/l

—

Type 2 diabetes

210

969

1.29

2.99

1.2

0.12

0.63

g/l

2.65

In situ neoplasms

413

1.55

2.96

1.2

0.32

0.34

g/l

—

Secondary uncertain malignant neoplasm

141

1.99

2.94

1.4

1.2

1.18

0.22

g/l

—

Alcohol use disorder, Swedish definition

112

745

1.40

2.94

1.2

0.18

0.48

g/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

318

1.64

2.92

1.2

—

0.22

g/l

—

Coxarthrosis

434

1.45

2.91

1.2

0.20

0.51

g/l

—

123

803

1.37

2.90

1.2

0.18

0.46

g/l

—

Other symptoms and signs involving cognitive functions and awareness

538

1.47

2.87

1.1

1.2

0.53

0.32

g/l

—

116

771

1.38

2.87

1.3

1.2

0.19

0.47

g/l

—

Sub-endpoint used in defining T1D endpoints

399

1.55

2.86

1.2

0.08

0.23

g/l

—

Dental caries 3 and operation codes

196

777

1.30

2.85

1.2

0.30

0.42

g/l

0.22

Injuries to the ankle and foot

145

991

1.33

2.85

1.4

1.2

0.98

0.32

g/l

—

123

2.04

2.81

1.3

1.2

—

0.25

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

2.23

2.80

1.3

1.1

—

0.04

g/l

—

Crohn disease

187

1.82

2.78

1.1

1.2

—

0.24

g/l

—

Injury of other and unspecified intrathoracic organs

2.32

2.74

1.1

1.2

—

0.07

g/l

—

Sleep apnoea

191

1011

1.28

2.73

1.2

0.77

0.47

g/l

0.28

Occupational exposure to risk-factors

2.73

2.72

1.0

1.3

—

0.07

g/l

—

Exposure to other and unspecified forces of nature

6.15

2.72

1.5

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

585

1.41

2.71

1.3

1.2

0.72

0.49

g/l

—

Dizziness and giddiness

150

925

1.32

2.69

1.3

1.2

0.40

0.56

g/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

2.22

2.63

1.2

1.1

—

0.04

g/l

—

Demyelinating diseases of the central nervous system

120

2.01

2.60

1.2

1.1

—

0.11

g/l

—

Hypertensive encephalopathy

7.38

2.57

1.0

—

Complications peculiar to reattachment and amputation

7.27

2.56

1.2

1.1

—

g/l

—

Other bursitis of elbow

7.25

2.56

1.0

—

Benign neoplasm of bone and articular cartilage

2.13

2.54

1.1

1.2

—

0.06

—

Asthma and opportunity respiratory infection

2.51

2.53

1.2

—

0.43

—

Nonorganic sleeping disorders

254

1.66

2.50

1.2

—

0.22

g/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

198

958

1.26

2.50

1.1

1.2

0.09

0.56

g/l

2.44

Diseases of the ear and mastoid process

257

1059

1.23

2.46

1.2

0.71

0.51

g/l

0.24

Obesity, other/unspecified

479

1.46

2.45

1.1

1.2

—

0.22

g/l

—

Other viral diseases, not elsewhere classified

248

1.65

2.43

1.1

1.2

—

0.21

g/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

159

1.83

2.43

1.3

1.1

1.18

0.09

g/l

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

0.00

2.42

0.0

1.2

—

0.07

—

Cholinergic urticaria

6.39

2.38

1.2

1.0

—

g/l

—

Spondylolisthesis/Spondylolysis

213

1.69

2.35

1.1

—

0.31

g/l

—

Bronchiectasis

2.15

2.34

1.2

1.3

—

0.32

—

Acute pancreatitis

244

1.64

2.33

1.2

0.21

0.27

g/l

—

Use of donepezil

179

0.38

2.27

1.1

1.3

—

0.42

—

Other shoulder lesions

2.07

2.26

1.1

1.2

—

0.25

g/l

—

Other disorders of eyelid

551

1.40

2.26

1.2

0.24

0.61

g/l

—

Thyrotoxicosis with diffuse goitre

172

1.75

2.20

1.1

1.2

—

0.29

g/l

—

Other symptoms and signs involving the urinary system

114

1.93

2.20

1.1

1.2

—

0.11

g/l

—

In situ neoplasms

466

1.44

2.19

1.2

0.32

0.27

g/l

—

Hernia

192

1051

1.24

2.15

1.3

1.2

0.66

0.49

g/l

0.18

Retinal vascular occlusion

115

1.92

2.15

1.1

1.3

—

0.24

g/l

—

Cholera

2.37

2.12

1.1

1.2

—

0.41

g/l

—

Presence of cardiac and vascular implants and grafts

422

1.40

2.12

1.2

0.12

0.71

g/l

—

Sleep disorders

285

1.55

2.04

1.2

—

0.22

g/l

—

Injuries to the wrist and hand

200

1186

1.22

2.01

1.2

0.10

0.58

g/l

—

Perineal laceration during delivery

220

0.44

2.01

1.1

1.2

—

0.19

—

Suggestive for eosinophilic asthma

111

1.90

2.00

1.1

1.2

—

0.26

g/l

—

Diabetes, insulin treatment (Kela reimbursement)

205

1027

1.22

2.00

1.1

1.2

0.09

0.56

g/l

2.52

Acute pancreatitis (for exclusion)

255

1.57

2.00

1.2

0.21

0.24

g/l

—

Dental operations, only avohilmo

147

592

1.27

1.99

1.2

0.16

0.35

g/l

—

Injuries to the shoulder and upper arm

161

1083

1.25

1.99

1.2

0.74

0.48

g/l

—

Glucosamine medication

540

1.35

1.98

1.1

1.2

0.39

0.52

g/l

—

Atypical facial pain

2.29

1.97

1.2

1.3

—

0.36

g/l

—

Use of amantadine

3.36

1.97

1.0

—

g/l

—

Retinal vascular disorders

119

1.85

1.96

1.1

1.3

—

0.49

g/l

—

Carpal tunnel syndrome

116

811

1.29

1.94

1.2

0.25

0.55

g/l

—

Herpesviral [herpes simplex] infections

150

1.74

1.90

1.3

1.2

—

0.29

g/l

—

Seborrhoeic dermatitis

1.92

1.90

1.1

1.2

—

0.13

—

Other disorders of ear

179

971

1.23

1.89

1.3

1.2

0.86

0.47

g/l

0.36

Contact with machinery

142

0.35

1.87

1.0

1.2

—

0.13

—

Abnormal weight loss

107

1.87

1.86

1.3

—

0.27

g/l

—

L02BX Other hormone antagonists and related agents

0.00

1.85

0.0

1.3

—

0.08

—

Other and unspecified glaucoma

2.03

1.85

1.2

—

0.10

g/l

—

Inflammatory disease of uterus

182

1.65

1.84

1.1

1.2

—

0.37

g/l

—

Osteonecrosis due to drugs

3.57

1.84

1.2

1.1

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

3.55

1.84

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage

4.22

1.83

1.2

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

184

0.43

1.79

1.0

1.1

—

0.09

—

Myocardial infarction, without ST-elevation

432

1.39

1.79

1.3

1.2

0.05

0.49

g/l

—

Exclusions for E4_PCOS_CONSORTIUM

147

741

1.24

1.75

1.2

0.21

0.44

g/l

—

Benign neoplasm of bone and articular cartilage

110

1.82

1.72

1.1

1.2

—

0.25

—

Intracranial and intraspinal abscess and granuloma

3.88

1.72

1.2

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

3.86

1.71

1.0

1.1

—

g/l

—

IBD patients in KELA-register

315

1.46

1.70

1.2

—

0.23

g/l

—

Chondropathies

218

1.56

1.70

1.1

1.2

—

0.22

g/l

—

Insomnia

226

1.55

1.70

1.2

—

0.24

g/l

—

Benign neoplasm: Colon, unspecified

265

1.50

1.69

1.1

—

0.11

g/l

—

Benign neoplasm of breast

141

1.71

1.67

1.2

1.1

—

0.08

g/l

—

Overexertion and strenuous or repetitive movements

134

1.72

1.65

1.2

—

0.11

—

Other disorders of optic [2nd] nerve and visual pathways

1.98

1.64

1.3

1.2

—

0.06

g/l

—

Personal history of other diseases and conditions

134

1.71

1.63

1.1

—

0.12

g/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

3.62

1.62

1.4

1.1

—

g/l

—

Nonpyogenic thrombosis of intracranial venous system

3.61

1.62

1.2

1.1

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

3.61

1.62

1.0

1.1

—

Benign neoplasm: Other and unspecified parts of mouth

2.34

1.60

1.1

1.2

—

0.07

g/l

—

Exposure to other specified factors

142

1086

1.23

1.60

1.3

1.2

0.13

0.48

g/l

—

Cervicocranial syndrome

113

1.77

1.60

1.1

—

0.19

g/l

—

Congenital malformations, deformations and chromosomal abnormalities

116

887

1.25

1.59

1.2

0.16

0.34

g/l

—

Eosinophilic disease (BM)

3.02

1.58

1.0

1.1

—

Other hearing loss

323

1.43

1.57

1.4

1.2

0.34

0.16

g/l

—

Other disorders of gingiva or/and edentulous alveolar ridge

2.21

1.57

1.3

1.2

—

0.42

—

Any event in cancer register

186

921

1.20

1.56

1.2

0.61

0.29

g/l

0.54

Fracture of shoulder and upper arm

490

1.35

1.56

1.2

0.21

0.27

g/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

114

1.76

1.56

1.2

1.3

—

0.24

g/l

—

Infective bursitis

2.43

1.54

1.3

1.2

—

0.07

—

Coronary atherosclerosis

123

637

1.25

1.53

1.2

0.10

0.75

g/l

2.43

MS-disease / Multiple Sclerosis

100

1.80

1.53

1.2

1.1

—

0.06

g/l

—

Synovial cyst of popliteal space [Baker]

2.00

1.48

1.0

1.3

—

0.28

g/l

—

Allergic rhinitis

439

1.35

1.48

1.1

1.2

—

0.22

g/l

—

Sequelae of injuries of lower limb

116

1.73

1.48

1.1

1.2

—

0.09

—

Phobic anxiety disorders

178

1.57

1.48

1.1

—

0.13

g/l

—

Other disorders of glucose regulation and pancreatic internal secretion

1.81

1.47

1.2

—

0.06

g/l

—

Inflammatory bowel disease, strict (require KELA)

326

1.41

1.46

1.2

—

0.23

g/l

—

Sleep apnoea, including avohilmo

192

1053

1.18

1.45

1.2

0.77

0.51

g/l

0.24

Vasomotor and allergic rhinitis

558

1.31

1.45

1.1

1.2

—

0.25

g/l

—

Mucosal proctocolitis

179

1.57

1.45

1.2

—

0.11

g/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

1.88

1.44

1.1

1.2

—

0.21

g/l

—

Need for other prophylactic measures

1.92

1.44

1.1

1.2

—

0.12

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

110

1.73

1.42

1.2

1.1

—

0.17

g/l

—

Type 2 diabetes, strict (exclude DM1)

183

922

1.19

1.40

1.1

1.2

0.14

0.58

g/l

—

Benign neoplasm: Rectosigmoid junction

2.26

1.40

1.1

1.3

—

0.07

—

Polyp of the female genital tract

303

1.33

1.39

1.1

1.2

0.66

0.55

g/l

—

Type 2 diabetes, definitions combined

182

917

1.18

1.39

1.1

1.2

0.14

0.59

g/l

—

Artrosis, including avohilmo

175

808

1.19

1.37

1.2

0.41

0.34

g/l

—

Diabetes medication

204

1061

1.17

1.34

1.1

1.2

0.12

0.58

g/l

2.60

Myocardial infarction

492

1.27

1.33

1.2

0.05

0.67

g/l

—

Use of memantine

204

0.55

1.32

1.1

1.2

—

0.43

g/l

—

Use of other anti-dementia drugs

204

0.55

1.32

1.1

1.2

—

0.43

g/l

—

Vitreous haemorrhage

113

1.68

1.31

1.1

1.3

—

0.26

g/l

—

Other noninflammatory disorders of vulva and perineum

113

1.68

1.31

1.0

1.2

—

0.05

g/l

—

Congenital malformations of heart and great arteries

163

1.55

1.29

1.0

1.2

—

0.09

g/l

—

Spirochaetal infections, other/unspecified

106

1.70

1.29

1.1

1.3

—

0.24

—

Nail disorders

106

1.70

1.29

1.1

1.2

—

0.10

—

Dental caries 2

154

1019

1.19

1.28

1.2

1.01

0.45

g/l

—

Other disorders of breast

175

0.51

1.28

1.2

1.1

—

0.32

—

Dental caries 2 and operation codes

151

1009

1.19

1.28

1.2

1.16

0.46

g/l

—

Contact with other sharp object(s)

1.79

1.27

1.3

1.1

—

0.04

g/l

—

Exposure to other and unspecified inanimate mechanical forces

1.79

1.27

1.3

1.2

—

0.05

g/l

—

Dementia in Alzheimer disease

135

0.51

1.26

1.1

1.2

—

0.27

g/l

—

Mental and behavioural disorders due to alcohol

713

1.24

1.23

1.2

0.13

0.48

g/l

—

Other keratitis

155

1.55

1.22

1.1

1.2

—

0.12

g/l

—

Heartburn

116

1.64

1.21

1.1

1.2

—

0.33

—

Benign neoplasm of breast

156

1.54

1.19

1.2

1.1

—

0.37

g/l

—

Other and unspecified injuries of head

1.84

1.19

1.3

1.2

—

0.25

g/l

—

Malignant neoplasm of skin

105

648

1.22

1.18

1.2

0.61

0.56

g/l

—

Degenerative macular diseases

125

1.60

1.17

1.1

1.2

—

0.55

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

436

1.26

1.17

1.1

1.2

0.71

0.38

g/l

—

Essential (haemorrhagic) thrombocythaemia

2.01

1.16

1.1

1.3

—

0.07

—

Malignant neoplasm of digestive organs

467

0.72

1.15

1.2

—

0.44

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

575

1.24

1.15

1.2

0.71

0.47

g/l

—

Tinnitus

325

1.36

1.15

1.2

—

0.18

g/l

—

Benign neoplasm: Skin of eyelid, including canthus

175

1.49

1.12

1.0

1.1

—

0.08

g/l

—

Retention of urine

341

1.31

1.12

1.2

0.17

0.40

g/l

—

Benign neoplasm: Transverse colon

104

1.64

1.09

1.2

—

0.06

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

425

1.25

1.08

1.1

1.2

0.61

0.41

g/l

—

Leiomyoma of uterus

587

0.81

1.07

1.2

0.27

0.51

g/l

—

Type 2 diabetes, definitions combined, including avohilmo

180

924

1.15

1.06

1.1

1.2

0.15

0.58

g/l

—

Benign neoplasm: Colon, unspecified

297

1.35

1.03

1.1

1.2

—

0.34

g/l

—

Colorectal adenocarcinoma

228

0.61

1.03

1.4

1.2

—

0.22

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

122

1.56

1.02

1.2

1.1

—

0.19

g/l

—

Superficial injury of hip and thigh

155

1.48

1.00

1.2

—

0.25

g/l

—

Thyroiditis

1.65

1.00

1.2

1.3

—

0.28

g/l

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

429

1.24

1.00

1.1

1.2

0.61

0.39

g/l

—

Alcohol use disorder, ICD-based

582

1.24

1.00

1.2

0.13

0.52

g/l

—

Foreign body on external eye

201

0.60

0.99

1.2

—

0.12

g/l

—

Basal cell carcinoma

592

1.21

0.99

1.2

0.61

0.48

g/l

—

Colon adenocarcinoma

133

0.53

0.98

1.6

1.3

—

0.23

g/l

—

Gastric ulcer

206

1.41

0.98

1.2

—

0.23

g/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

628

1.23

0.98

1.2

0.13

0.49

g/l

—

Diseases of male genital organs

388

1.21

0.97

1.2

0.20

0.58

g/l

—

Otosclerosis

100

1.60

0.96

1.0

1.3

—

0.24

g/l

—

Acute pharyngitis

197

1.41

0.96

1.1

1.2

—

0.15

g/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

182

1.43

0.95

1.2

—

0.23

g/l

—

Diplopia

149

1.48

0.95

1.0

1.2

—

0.22

g/l

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

497

1.21

0.95

1.2

0.75

0.36

g/l

—

Haemorrhoids and perianal venous thrombosis

373

1.29

0.93

1.3

1.2

0.86

0.27

g/l

—

Endometriosis of pelvic peritoneum

231

1.37

0.92

1.0

1.2

—

0.18

g/l

—

Major coronary heart disease event excluding revascularizations

111

650

1.18

0.92

1.2

0.05

0.68

g/l

—

Coxarthrosis, primary

717

1.19

0.90

1.2

0.98

0.58

g/l

—

Basal cell carcinoma, including avohilmo

600

1.19

0.89

1.2

0.61

0.47

g/l

—

Lateral epicondylitis

143

1.47

0.89

1.0

1.2

—

0.25

g/l

—

Benign neoplasm: Skin of eyelid, including canthus

185

1.41

0.89

1.0

1.2

—

0.23

g/l

—

Use of disulfiram, acamprosate or naltrexone

127

0.55

0.88

1.3

1.2

—

0.08

—

Angina pectoris

101

578

1.18

0.86

1.3

1.2

0.11

0.78

g/l

—

Early lumbar disc prolapse, operated

120

1.50

0.85

1.1

—

0.23

g/l

—

Delivery

363

0.80

0.85

1.2

1.3

0.06

0.47

g/l

—

Glaucoma

682

1.18

0.84

1.2

1.85

0.39

g/l

—

Other (not insulin) diabetes medications

181

966

1.13

0.84

1.1

1.2

0.13

0.58

g/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

1.67

0.84

1.1

1.3

—

0.30

—

Disorders of breast

701

0.82

0.83

1.1

1.2

—

0.60

g/l

—

Benign neoplasm: Small intestine

1.74

0.82

1.3

1.2

—

0.06

—

Struck by thrown, projected or falling objec

1.70

0.82

1.0

1.2

—

0.06

—

Crohn's disease of small intestine

1.55

0.81

1.3

1.2

—

0.10

g/l

—

Leiomyoma of uterus

427

0.82

0.81

1.1

1.2

0.27

0.15

g/l

—

L02BA Anti-estrogens

213

0.66

0.81

1.2

1.1

—

0.30

—

Other vitreous opacities

1.71

0.80

1.1

1.2

—

0.12

g/l

—

Paralytic ileus and intestinal obstruction

312

1.28

0.78

1.1

1.2

—

0.28

g/l

—

Thyrotoxicosis with toxic multinodular goitre

1.63

0.78

1.3

—

0.36

g/l

—

Tonsillectomy and adenotomy

111

668

1.16

0.77

1.1

1.2

0.06

0.32

g/l

—

Alzheimer’s disease, wide definition

196

0.68

0.77

1.2

—

0.41

g/l

—

Abscess of anal and rectal regions

107

1.50

0.76

1.1

1.2

—

0.10

—

Pneumothorax

1.57

0.75

1.0

1.2

—

0.12

—

Macular hole

1.67

0.74

1.1

1.4

—

0.32

—

Bacterial, viral and other infectious agents

116

1.47

0.74

1.2

1.1

—

0.10

g/l

—

Hypertrophy of breast in women and men

278

0.72

0.74

1.0

1.2

—

0.20

g/l

—

Presence of other devices

266

0.71

0.73

1.1

—

0.18

—

Radial styloid tenosynovitis [de Quervain]

1.64

0.73

1.0

1.3

—

0.32

—

Other complications of labour and delivery, not elsewhere classified

154

0.62

0.73

1.0

1.2

—

0.14

g/l

—

Progressive vascular leukoencephalopathy

2.00

0.72

1.0

1.2

—

Other diseases of gallbladder

1.61

0.72

1.2

1.3

—

0.43

g/l

—

Hypertrophy of breast

242

0.70

0.72

1.0

1.2

—

0.23

g/l

—

Benign neoplasm: Transverse colon

117

1.46

0.71

1.2

1.3

—

0.23

—

Chronic diseases of tonsils and adenoids

152

855

1.13

0.71

1.1

1.2

0.19

0.53

g/l

—

Ulcerative proctitis

1.53

0.69

1.2

1.1

—

0.04

g/l

—

Hallux rigidus

152

1.38

0.69

1.1

1.2

—

0.19

g/l

—

Hypoglycaemia, other or unspecified

1.56

0.68

1.1

—

0.04

—

Childhood asthma (age<16)

127

1.38

0.68

1.1

1.2

—

0.25

g/l

—

Smoking dependency

119

0.59

0.67

1.0

1.2

—

0.13

g/l

—

Coxarthrosis, primary, with hip surgery

597

1.18

0.67

1.2

1.17

0.50

g/l

—

Mental and behavioural disorders due to tobacco

121

0.58

0.67

1.0

1.2

—

0.13

g/l

—

Intestinal adhesions without obstruction

1.49

0.66

1.2

—

0.12

g/l

—

Malignant neoplasm of head and neck

0.53

0.66

1.0

1.3

—

0.26

—

Ulcerative rectosigmoiditis

111

1.44

0.65

1.1

1.2

—

0.12

g/l

—

Generalized anxiety disorder

197

1.32

0.65

1.2

—

0.13

—

Childhood asthma (age<16), excluding more controls

128

1.36

0.65

1.1

1.2

—

0.25

g/l

—

Major coronary heart disease event

118

694

1.13

0.65

1.3

1.2

0.18

0.71

g/l

—

Malignant neoplasm of colon

166

0.66

0.64

1.4

1.2

—

0.24

g/l

—

Endometriosis ASRM stages 1,2

251

1.28

0.63

1.0

1.2

—

0.27

g/l

—

Colorectal cancer

281

0.75

0.63

1.3

1.2

—

0.31

g/l

—

Congenital malformations of genital organs

130

0.61

0.63

1.3

1.1

—

0.12

g/l

—

Benign neoplasm: Skin of ear and external auricular canal

1.64

0.62

1.0

1.2

—

0.06

—

Alcohol dependence

370

1.22

0.61

1.2

0.13

0.22

g/l

—

Obstructive hydrocephalus

0.00

0.60

0.0

1.1

—

Brain glioblastoma and astrocytoma

0.00

0.60

0.0

1.1

—

Burns and corrosions of external body surface, specified by site

139

0.65

0.60

1.0

1.2

—

0.10

g/l

—

Adhesive middle ear disease

0.00

0.60

0.0

1.0

—

Unspecified/other endometriosis

131

1.38

0.59

1.1

1.2

—

0.12

g/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

197

0.71

0.58

1.4

1.2

—

0.15

g/l

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

114

0.61

0.58

1.6

1.2

—

0.06

g/l

—

Bicipital tendinitis

1.48

0.57

1.0

1.1

—

0.12

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

124

1.37

0.55

1.1

1.3

—

0.21

g/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

288

0.81

0.55

1.0

1.2

—

0.44

g/l

—

Noninflammatory disorders of female genital tract

364

1.15

0.54

1.2

0.42

0.53

g/l

—

Bitten or struck by other mammals

160

1.31

0.53

1.1

1.2

—

0.28

g/l

—

Speech and linguistic disorders, excluding more controls

1.52

0.52

1.0

1.2

—

0.08

g/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.47

0.50

1.1

1.2

—

0.10

g/l

—

Pedestrian injured in transport accident

1.41

0.50

1.3

1.2

—

0.09

g/l

—

Tobacco use

1.50

0.49

1.1

1.2

—

0.05

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

101

1.39

0.49

1.2

1.1

—

0.13

g/l

—

Conductive and sensorineural hearing loss

133

836

1.10

0.49

1.2

1.21

0.51

g/l

—

Other or unspecified ileus, impaction or obstruction

207

1.26

0.49

1.0

1.1

—

0.31

g/l

—

Benign neoplasm: Caecum

110

1.37

0.48

1.1

1.2

—

0.09

g/l

—

Benign lipomatous neoplasm of other sites/unspecified

110

0.64

0.48

1.1

1.3

—

0.25

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

110

0.64

0.48

1.1

1.3

—

0.27

—

Infections of genitourinary tract in pregnancy

137

1.32

0.47

1.1

1.2

—

0.34

—

Burns and corrosions

177

0.73

0.47

1.0

1.2

—

0.14

g/l

—

Persons encountering health services in circumstances related to reproduction

104

634

1.11

0.46

1.2

0.80

0.20

g/l

—

Dental caries 2, only avohilmo

140

1010

1.09

0.46

1.2

1.01

0.45

g/l

—

Hydrocephalus

0.62

0.45

1.0

1.3

—

0.29

—

Impacted cerumen

118

0.68

0.45

1.1

1.2

—

0.27

—

Biguanides

171

972

1.08

0.45

1.1

1.2

0.13

0.54

g/l

—

Parkinson's disease, strict definition

153

0.72

0.45

1.1

1.2

—

0.23

g/l

—

Viral and other specified intestinal infections

268

1.20

0.44

1.2

1.1

—

0.28

g/l

—

Childhood allergy (age < 16)

144

0.74

0.43

1.2

1.1

—

0.08

g/l

—

Other diseases of biliary tract

104

1.35

0.43

1.1

1.2

—

0.33

g/l

—

Medical abortion

114

564

1.10

0.41

1.2

0.50

g/l

—

Endometriosis of fallopian tube

0.00

0.41

0.0

1.1

—

Brain glioblastoma

0.00

0.41

0.0

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.41

0.0

1.1

—

Use of fingolimod

0.00

0.41

0.0

1.0

—

Contact with venomous snakes and lizards

0.00

0.41

0.0

1.1

—

Mesothelioma

0.00

0.41

0.0

1.1

—

Disorder of thyroid, unspecified

0.00

0.41

0.0

1.0

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.0

—

Tularaemia

0.00

0.40

0.0

1.1

—

Oral leukoplakia and related diseases, including avohilmo

114

1.32

0.40

1.0

1.2

—

0.26

g/l

—

Vestibular neuronitis

114

1.32

0.40

1.1

1.3

—

0.25

—

Other disorders of penis

114

1.32

0.40

1.2

—

0.13

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

194

0.77

0.40

1.3

1.2

—

0.15

g/l

—

Cellulitis of external ear

0.00

0.40

0.0

1.1

—

Other and unspecified hydrocephalus

0.00

0.40

0.0

1.1

—

Additional codes for the location of defect, injury or illness

1.41

0.39

1.1

1.2

—

0.04

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

106

0.66

0.39

1.1

1.3

—

0.27

—

Paralytic strabismus

1.38

0.38

1.0

1.3

—

0.11

g/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

215

1.21

0.38

1.2

—

0.23

g/l

—

Diseases of inner ear

782

1.10

0.37

1.1

1.2

0.19

0.57

g/l

—

Benign neoplasm: Choroid

1.32

0.37

1.1

1.3

—

0.07

—

Abnormalities of forces of labour

147

0.75

0.37

1.2

1.1

—

0.16

g/l

—

Transient global amnesia

116

1.29

0.37

1.2

1.3

—

0.26

g/l

—

Benign neoplasm: Choroid

1.27

0.36

1.1

1.3

—

0.32

—

Sequelae of injuries of upper limb

126

1.27

0.35

1.0

1.2

—

0.24

g/l

—

Assault

190

1.21

0.34

1.2

—

0.10

g/l

—

Effects of foreign body entering through natural orifice

351

0.85

0.34

1.1

1.2

—

0.21

g/l

—

Hydrocele

136

1.25

0.33

1.4

1.2

—

0.13

g/l

—

Single delivery by forceps and vacuum extractor

155

0.82

0.33

1.1

1.2

—

0.07

—

Alzheimer’s disease (Late onset)

170

0.81

0.32

1.2

—

0.47

g/l

—

Hydronephrosis

110

1.27

0.31

1.0

1.1

—

0.11

—

Insulin, fast-acting (human)

211

1.19

0.31

1.4

1.2

0.07

0.12

g/l

—

Vascular syndromes of brain in cerebrovascular disorders

1.35

0.31

1.0

1.2

—

0.06

—

Bronchitis, not specified as acute or chronic

0.72

0.30

1.3

1.2

—

0.26

g/l

—

Persistent delusional disorders

0.71

0.30

1.1

1.2

—

0.30

—

Benign lipomatous neoplasm of other sites/unspecified

0.71

0.30

1.1

1.2

—

0.07

—

Benign neoplasm: Caecum

120

1.25

0.30

1.1

1.3

—

0.25

g/l

—

Other osteochondropathies

1.29

0.30

1.1

1.2

—

0.06

g/l

—

Sensorineural hearing loss

121

790

1.07

0.29

1.2

1.09

0.51

g/l

—

Parkinson's disease, including avohilmo

174

0.80

0.29

1.1

1.2

—

0.22

g/l

—

Herpesviral keratitis and keratoconjunctivitis

1.25

0.29

1.1

1.2

—

0.12

g/l

—

Respiratory tuberculosis

1.25

0.29

1.3

—

0.07

g/l

—

Respiratory tuberculosis, confirmed and not-confirmed

1.25

0.29

1.3

—

0.07

g/l

—

Outcome of delivery

154

1.17

0.29

1.0

1.1

—

0.08

—

Dental caries 2 and operation codes, only avohilmo

126

731

1.07

0.29

1.2

1.16

0.64

g/l

—

Foreign body entering into or through eye or natural orifice

108

0.74

0.29

1.1

1.2

—

0.07

g/l

—

Other disorders of cornea

121

1.24

0.28

1.0

1.2

—

0.12

g/l

—

Nasal polyp

251

1.16

0.28

1.1

1.2

—

0.24

g/l

—

Diseases of middle ear and mastoid

102

777

1.08

0.28

1.3

1.2

0.25

g/l

—

Conductive hearing loss, unspecified

103

1.26

0.28

1.1

1.2

—

0.13

g/l

—

Tuberculosis, IBD comorbidity

1.32

0.28

1.3

—

0.30

g/l

—

Carcinoma in situ of cervix uteri

129

0.77

0.28

1.0

1.1

—

0.13

g/l

—

Spontaneous rupture of synovium and tendon

1.32

0.28

1.0

1.3

—

0.28

g/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.29

0.28

1.3

1.2

—

0.06

—

Other peripheral vertigo

119

0.76

0.27

1.3

—

0.23

g/l

—

Caught, crushed, jammed or pinched in or between objects

1.23

0.27

1.1

1.2

—

0.04

g/l

—

Other ill-defined and unspecified causes of mortality

1.23

0.27

1.0

1.3

—

0.07

g/l

—

Fall on and from ladder

1.26

0.26

1.0

1.2

—

0.10

g/l

—

Other and unspecified vascular occlusions

1.26

0.26

1.1

1.3

—

0.24

g/l

—

Melanocytic naevi of other and unspecified parts of face

1.23

0.25

1.1

1.2

—

0.11

—

Lesion of plantar nerve

1.23

0.25

1.3

—

0.33

g/l

—

Coronary angioplasty

375

0.90

0.25

1.7

1.2

0.29

0.76

g/l

—

Ptosis of eyelid

123

1.22

0.25

1.1

1.2

—

0.28

—

Perforation of tympanic membrane

126

0.79

0.24

1.2

—

0.26

g/l

—

Varicose veins of other sites

0.73

0.24

1.0

1.3

—

0.26

—

Early lumbar disc prolapse operation

152

1.18

0.23

1.1

—

0.07

g/l

—

Parkinson's disease

168

0.83

0.22

1.1

1.2

—

0.22

g/l

—

Complications of labour and delivery

582

0.94

0.22

1.2

1.51

0.42

g/l

—

Other appendicitis

116

1.21

0.22

1.1

1.2

—

0.12

g/l

—

Mixed conductive and sensorineural hearing loss

144

1.18

0.22

1.2

1.1

—

0.16

—

Adenocarcinomas of cervix

0.00

0.21

0.0

1.1

—

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.1

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.1

—

Complex cardiac defects

0.00

0.21

0.0

1.0

—

Contact with blunt object, undetermined intent

0.00

0.21

0.0

1.0

—

Common variable immunodeficiency

0.00

0.21

0.0

1.1

—

Malignant neoplasm of nasal cavity and sinuses

0.00

0.21

0.0

1.0

—

Degenerative myopia

0.00

0.21

0.0

1.1

—

Increased muscle tone

0.00

0.21

0.0

1.1

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.0

—

Other and unspecified primary disorders of muscles

0.00

0.21

0.0

1.1

—

Effects of heat and light

0.00

0.21

0.0

1.0

—

Congenital malformations of pulmonary and tricuspid valves

0.00

0.21

0.0

1.0

—

Sequelae of poliomyelitis

0.00

0.21

0.0

1.1

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs

0.00

0.21

0.0

1.1

—

Tic and related disorders

0.00

0.21

0.0

1.0

—

Dislocation of lens

0.00

0.21

0.0

1.0

—

Mixed specific developmental disorders

0.00

0.21

0.0

1.1

—

Crowding of teeth, including avohilmo

0.78

0.21

1.5

1.2

—

0.04

—

Neuroendocrine tumor and carcinoma of lung

0.00

0.21

0.0

1.1

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Emergency coronary revascularization (for ACS)

525

0.93

0.21

1.5

1.2

0.20

0.65

g/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

101

0.79

0.21

1.1

1.2

—

0.06

—

Other obstructed labour

102

0.78

0.21

1.1

—

0.21

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

294

0.89

0.21

1.3

1.1

—

0.13

g/l

—

Other noninflammatory disorders of uterus, except cervix

221

1.11

0.21

1.6

1.2

0.49

0.67

g/l

—

Short stature, not elsewhere classified

0.00

0.21

0.0

1.2

—

Postpartum haemorrhage due to retained placenta

145

0.83

0.21

1.2

1.3

—

0.25

—

Other benign neoplasm of uterus: Cervix uteri

0.00

0.21

0.0

1.1

—

Squamous cell neoplasms and carcinoma of cervix

0.00

0.21

0.0

1.1

—

Normotensive glaucoma

1.24

0.21

1.1

1.2

—

0.11

—

Coronary revascularization (ANGIO or CABG)

430

0.92

0.20

1.6

1.2

0.20

0.74

g/l

—

Secondary malignant neoplasm of other and unspecified sites

0.00

0.20

0.0

1.1

—

Gastrojejunal ulcer

0.00

0.20

0.0

1.1

—

Intentional self-harm by unspecified means

0.00

0.20

0.0

1.1

—

Malignant neoplasm of larynx

0.00

0.20

0.0

1.1

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.0

—

Oesophageal obstruction

1.25

0.20

1.2

—

0.13

—

Multiple delivery

136

1.18

0.20

1.0

1.2

—

0.38

—

Follicular lymphoma

1.23

0.20

1.0

1.2

—

0.08

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

112

0.80

0.20

1.0

1.2

—

0.06

—

Divergent concomitant strabismus

1.21

0.19

1.2

—

0.10

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

250

1.12

0.19

1.2

—

0.22

g/l

—

Pyothorax

1.18

0.19

1.0

1.2

—

0.06

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

100

1.20

0.18

1.1

1.2

—

0.09

g/l

—

Malignant neoplasm of kidney, except renal pelvis

100

1.20

0.18

1.8

1.3

—

0.27

—

Lung diseases due to external agents

147

1.16

0.18

1.0

1.2

—

0.23

g/l

—

Biomechanical lesions, not elsewhere classified

1.17

0.17

1.0

1.2

—

0.12

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

1.17

0.17

1.1

1.3

—

0.06

—

Pregnancy examination and test

151

1.12

0.17

1.0

1.1

—

0.08

g/l

—

Endovascular or surgical operations to intracerebral aneurysms

1.22

0.17

1.0

1.3

—

0.13

g/l

—

Tuberculosis, wide

1.22

0.17

1.3

—

0.27

g/l

—

Tuberculosis

1.11

0.17

1.3

—

0.11

g/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

224

1.12

0.17

1.2

—

0.22

g/l

—

Antepartum haemorrhage, not elsewhere classified

120

0.83

0.16

1.3

1.1

—

0.09

—

Type1 diabetes, definitions combined, early onset

1.22

0.16

1.1

—

0.09

g/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.16

0.16

1.3

1.2

—

0.04

—

Ill-defined and unknown causes of mortality

1.14

0.16

1.0

1.3

—

0.07

g/l

—

Parkinson's disease, excluding more controls

117

1.17

0.16

1.1

—

0.06

g/l

—

Supervision of normal pregnancy

183

1.09

0.16

1.1

—

0.11

g/l

—

Hypermetropia

0.78

0.15

1.0

1.2

—

0.10

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

0.78

0.15

1.0

1.2

—

0.06

—

Otitis externa, unspecified

149

1.14

0.15

1.1

1.2

—

0.24

g/l

—

Other diseases of stomach and duodenum

0.76

0.15

1.5

1.3

—

0.30

g/l

—

Chronic laryngitis and laryngotracheitis

159

1.13

0.15

1.1

1.2

—

0.25

—

Other infective otitis externa

1.11

0.15

1.0

1.2

—

0.05

—

Foreign body or object entering through skin

0.79

0.14

1.0

1.2

—

0.06

g/l

—

Other disorders of amniotic fluid and membranes

190

0.89

0.14

1.2

1.1

—

0.16

g/l

—

Fitting and adjustment of other devices

373

1.07

0.14

1.1

1.2

—

0.59

g/l

—

Postpartum haemorrhage

329

0.93

0.14

1.2

1.1

—

0.17

g/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

141

1.14

0.13

1.1

—

0.19

g/l

—

Chronic suppurative otitis media, including avohilmo

0.83

0.13

1.0

1.3

—

0.09

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.82

0.13

1.1

1.2

—

0.06

—

Unspecified lump in breast

218

1.10

0.13

1.0

1.2

—

0.29

—

False labour

289

0.93

0.13

1.2

1.1

—

0.19

g/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

201

0.90

0.13

1.2

—

0.21

g/l

—

Inguinal hernia

609

1.04

0.12

1.2

0.07

0.51

g/l

—

Coronary artery bypass grafting

262

0.93

0.12

1.2

0.10

0.76

g/l

—

Drug-induced neutropenia

1.16

0.11

1.4

1.3

—

0.26

—

Lichen planus

147

0.88

0.11

1.2

—

0.29

g/l

—

Inguinal or femoral hernia, bilateral

126

0.87

0.11

1.0

1.1

—

0.09

g/l

—

Use of antiglaucoma preparations and miotics

1.16

0.11

1.3

1.2

—

0.10

g/l

—

Postpartum hemorraghe, all women as controls

370

0.94

0.10

1.2

—

0.23

g/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

106

1.13

0.09

1.1

1.2

—

0.10

g/l

—

Paralytic ileus

1.09

0.09

1.0

1.3

—

0.07

—

Alzheimer’s disease, wide definition, excluding more controls

106

0.90

0.09

1.2

1.1

—

0.06

g/l

—

Complications following abortion and ectopic and molar pregnancy

1.06

0.09

1.0

1.3

—

0.44

g/l

—

Monoarthritis, not elsewhere classified

1.04

0.09

1.2

1.1

—

0.19

g/l

—

Inguinal hernia, bilateral

124

0.89

0.09

1.0

1.1

—

0.09

g/l

—

Vasomotor rhinitis (mode)

1.13

0.09

1.4

1.2

—

0.25

g/l

—

Impotence

1.05

0.08

1.3

1.2

—

0.06

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

1.05

0.08

1.0

1.2

—

0.07

—

Calculus of lower urinary tract

0.82

0.08

1.0

1.3

—

0.07

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

0.83

0.08

1.2

1.3

—

0.07

g/l

—

Superficial injury of forearm

117

1.11

0.08

1.2

—

0.11

g/l

—

Ulcerative colitis (strict definition, require KELA)

234

1.07

0.08

1.2

—

0.22

g/l

—

Laparoscopic right hemicolectomy

0.86

0.07

1.8

1.4

—

0.27

—

Other ulcerative colitis

1.08

0.07

1.1

—

0.04

—

Diseases of tongue

1.07

0.07

1.0

1.2

—

0.44

g/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cryoglobulin [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS